China focus - cardiovascular disease and prostate cancer

Another of our special episodes with our Chinese team. We are joined by our Associate Editor for China, Yige Bao (SCU Hospital Xiamen, Xiamen City), and Junlong Zhang (Drum Tower Hospital, Nanjing), to discuss the topic of cardiovascualr disease in patients starting treatment for advanced prostate cancer. Some great practical advice on risk stratification for men starting intensified hormonal therapy.

With your regular co-Hosts, Renu Eapen and Declan Murphy

This is a Themed Podcast supported by our Gold Partner, Bayer Pharmaceuticals in China.

 

lso available as an audio podcast, just search GU Cast wherever you get yours. Or play directly below:

Next
Next

Journal Club | Intermittent hormonal therapy and open vs robot cystectomy